Thursday, 28 March 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 28 March 2024
Ascott 2
Ascott 2
FDA pulls wacky social media posts

The FDA has agreed to pull a string of uncharacteristically wacky social media posts - including one titled You Are Not A Horse - as part of a settlement agreement in the Texas Federal Court.

Hands up for an Aussie GM job
ICYMI: The stories that topped this week
TODAY Your week in Five Minutes
Pharma content doctors are craving
Nine areas where more information is needed
TODAY
Dear Minister, funding must change
New approach to reimbursing cancer meds goes to Canberra
TODAY
HPG
HPG
Ex-Novartis exec scores GM role
Marketing chief steps up to country leadership position
27 March
Is pharma overwhelming doctors?
'Digital exhaustion' behind doctors unsubscribing from pharma
27 March
Cancer drugs to lose crown
New top drug class is poised to take the throne this year
26 March
Who earned more than most CEOs?
Poached from another company, this boss has hit the jackpot
26 March
ADG
ADG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (5)

Sales & Customer Relations (16)

Clinical & Medical, R&D (13)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Other (28)

Novartis, Novo get the nod
EU recommendations a good sign for big drugs locally
TODAY
Gilead funds disease groups
Supporting community groups to drive meaningful change
TODAY
Pain clinic in your pocket
Aussie app aims to close the delay in diagnosis of endometriosis
27 March
Sanofi's next big move official
Blockbuster receives priority review for new market
27 March
FDA smiles on local companies
Two Aussie pharmas receive welcome news
27 March
Making precision care routine
Governments, universities, and not-for-profits team up
27 March
Aussies tip radiopharma revolution
Equity raising to advance portfolio in burgeoning sector
26 March
New drug filings on the horizon
TGA hands out pathways for three innovative drugs
26 March
More deals for Sanofi's RSV drug
Two more states will now roll out RSV programs
26 March
Pfizer releases annual scorecard
Fifth Impact Report reveals progress on ESG goals
26 March
Aussie GM job up for grabs
Which global company is scouting for a new leader?
25 March
$150K fine for Aussie Code breach
Plus loss of another $20K after failed appeal
25 March
Pfizer pulls a trump card in RSV
Among three new products approved by the TGA last week
25 March Approvals Action
Hunt begins for virus volunteers
First purpose-built facility for human challenge trials launched
25 March
PiF jobs
PiF jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.